(Q37318206)

19 August 2017

Fluoroquinolone resistance in Mycobacterium tuberculosis: the effect of duration and timing of fluoroquinolone exposure (English)

1 reference

Mycobacterium tuberculosis

19 August 2017

0 references

3

Tebeb Gebretsadik

1 reference

19 August 2017

4

Marie Griffin

1 reference

19 August 2017

Rose A Devasia

1

1 reference

19 August 2017

Amondrea Blackman

2

1 reference

19 August 2017

Ayumi Shintani

5

1 reference

19 August 2017

Carolyn May

6

1 reference

19 August 2017

Teresa Smith

7

1 reference

19 August 2017

Nancy Hooper

8

1 reference

19 August 2017

Fernanda Maruri

9

1 reference

19 August 2017

Jon Warkentin

10

1 reference

19 August 2017

Ed Mitchel

11

1 reference

19 August 2017

Timothy R Sterling

12

1 reference

19 August 2017

language of work or name

English

0 references

publication date

29 May 2009

1 reference

American Journal of Respiratory and Critical Care Medicine

19 August 2017

1 reference

19 August 2017

180

1 reference

19 August 2017

4

1 reference

19 August 2017

365-370

1 reference

A Phase II study of the sterilising activities of ofloxacin, gatifloxacin and moxifloxacin in pulmonary tuberculosis

19 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2731810

Infectious Diseases Society of America/American Thoracic Society Consensus Guidelines on the Management of Community-Acquired Pneumonia in Adults

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2731810

Fluoroquinolone prescribing in the United States: 1995 to 2002.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2731810

Evaluation of a two-step approach for large-scale, prospective genotyping of Mycobacterium tuberculosis isolates in the United States

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2731810

American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2731810

In-vitro activity of six fluorinated quinolones against Mycobacterium tuberculosis

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2731810

Impact of short-term exposure to fluoroquinolones on ofloxacin resistance in HIV-negative patients with tuberculosis.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2731810

In-vitro activity of fluorinated quinolones and macrolides against drug-resistant Mycobacterium tuberculosis

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2731810

Increasing outpatient fluoroquinolone exposure before tuberculosis diagnosis and impact on culture-negative disease

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2731810

Trends in tuberculosis incidence--United States, 2006.

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2731810

Limited fluoroquinolone resistance among Mycobacterium tuberculosis isolates from Rwanda: results of a national survey

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2731810

Fluoroquinolone susceptibility among Mycobacterium tuberculosis isolates from the United States and Canada

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2731810

Fluoroquinolone Resistance in Patients with Newly Diagnosed Tuberculosis

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2731810

The Rapid Development of Fluoroquinolone Resistance inM. tuberculosis

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2731810

The prevention of chronic obstructive pulmonary disease exacerbations by salmeterol/fluticasone propionate or tiotropium bromide

2 September 2018

1 reference

Crossref

https://api.crossref.org/works/10.1164%2FRCCM.200901-0146OC

Fluoroquinolone resistance in Mycobacterium tuberculosis isolates: associated genetic mutations and relationship to antimicrobial exposure

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/19483111

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1164/RCCM.200901-0146OC

1 reference

19 August 2017

1 reference

19 August 2017

1 reference